Table of Contents Table of Contents
Previous Page  243 / 671 Next Page
Information
Show Menu
Previous Page 243 / 671 Next Page
Page Background

Retreatment fase 3 trial SC20 → 50% responders

38

Chow et al. Lancet Oncol 2014

1 … 238 239 240 241 242 243 244 245 246 247 248 249 … 671  FlippingBook